Literature DB >> 4068882

Photodynamic therapy of gynecologic neoplasms after presensitization with hematoporphyrin derivative.

J S McCaughan, H F Schellhas, J Lomano, B H Bethel.   

Abstract

Five patients with various gynecologic neoplasms were treated with photodynamic therapy using 630-nm light delivered from an argon dye laser system following the intravenous injection of hematoporphyrin derivative (HpD). A patient with multifocal squamous cell cancer of the vagina had no evidence of disease 15 months after her first photodynamic therapy treatment. Autopsy nine months after the first treatment of another patient with multifocal invasive cancer of the vagina and parametrium showed no evidence of tumor on the surface of the vagina. Eight months after treatment of an 8 X 12 cm area of Bowen's disease of the vulva and thigh, there was no evidence of disease. Vaginal bleeding from breast cancer metastatic to the endometrium was controlled by one treatment until the patient expired five months later from her disease. Adenocarcinoma metastatic to the vaginal cuff showed partial response when vaginectomy was performed five weeks after photodynamic therapy.

Entities:  

Mesh:

Year:  1985        PMID: 4068882     DOI: 10.1002/lsm.1900050508

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  3 in total

1.  Response of human endometrium and ovarian carcinoma cell-lines to photodynamic therapy.

Authors:  G H Raab; A F Schneider; W Eiermann; H Gottschalk-Deponte; R Baumgartner; W Beyer
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

Review 2.  Photodynamic therapy: a review.

Authors:  J S McCaughan
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

Review 3.  Photodynamic Therapy in Gynecologic Malignancies: A Review of the Roswell Park Cancer Institute Experience.

Authors:  Paul C Mayor; Shashikant Lele
Journal:  Cancers (Basel)       Date:  2016-09-23       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.